Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 33 | 2024 | 1305 | 4.850 |
Why?
|
Endovascular Procedures | 35 | 2024 | 2135 | 4.010 |
Why?
|
Ischemia | 33 | 2024 | 1893 | 3.810 |
Why?
|
Vascular Surgical Procedures | 21 | 2024 | 1469 | 2.430 |
Why?
|
Lower Extremity | 14 | 2024 | 1196 | 2.390 |
Why?
|
Limb Salvage | 24 | 2024 | 466 | 2.270 |
Why?
|
Popliteal Artery | 5 | 2024 | 312 | 1.810 |
Why?
|
Blood Vessel Prosthesis Implantation | 14 | 2024 | 1426 | 1.550 |
Why?
|
Peripheral Vascular Diseases | 4 | 2023 | 515 | 1.390 |
Why?
|
Stents | 12 | 2020 | 3303 | 1.310 |
Why?
|
Saphenous Vein | 8 | 2024 | 538 | 1.120 |
Why?
|
Angioplasty, Balloon | 3 | 2016 | 597 | 0.880 |
Why?
|
Decompression, Surgical | 2 | 2024 | 604 | 0.860 |
Why?
|
Blood Vessel Prosthesis | 5 | 2021 | 945 | 0.750 |
Why?
|
Intermittent Claudication | 2 | 2016 | 305 | 0.710 |
Why?
|
Vascular Grafting | 9 | 2024 | 153 | 0.700 |
Why?
|
Aortic Aneurysm, Abdominal | 8 | 2022 | 1199 | 0.700 |
Why?
|
Extremities | 2 | 2016 | 867 | 0.690 |
Why?
|
Treatment Outcome | 58 | 2024 | 64947 | 0.670 |
Why?
|
Arterial Occlusive Diseases | 5 | 2024 | 752 | 0.630 |
Why?
|
Femoral Artery | 4 | 2018 | 831 | 0.620 |
Why?
|
Renal Artery | 5 | 2021 | 368 | 0.570 |
Why?
|
Aneurysm | 2 | 2010 | 337 | 0.570 |
Why?
|
Aneurysm, Infected | 3 | 2014 | 81 | 0.530 |
Why?
|
Research Design | 4 | 2024 | 6181 | 0.500 |
Why?
|
Reoperation | 12 | 2024 | 4292 | 0.490 |
Why?
|
Renal Artery Obstruction | 3 | 2021 | 224 | 0.460 |
Why?
|
Veins | 4 | 2023 | 765 | 0.460 |
Why?
|
Time Factors | 33 | 2024 | 40133 | 0.450 |
Why?
|
Transposition of Great Vessels | 1 | 2017 | 590 | 0.420 |
Why?
|
Vascular Patency | 10 | 2024 | 901 | 0.410 |
Why?
|
Quality of Life | 8 | 2024 | 13300 | 0.390 |
Why?
|
Polyethylene Terephthalates | 1 | 2012 | 115 | 0.390 |
Why?
|
Risk Factors | 34 | 2024 | 74269 | 0.380 |
Why?
|
Iliac Artery | 3 | 2019 | 344 | 0.340 |
Why?
|
Renal Veins | 1 | 2009 | 102 | 0.330 |
Why?
|
Patient Care Team | 3 | 2015 | 2510 | 0.330 |
Why?
|
Critical Illness | 12 | 2024 | 2709 | 0.330 |
Why?
|
Angioplasty | 1 | 2012 | 360 | 0.320 |
Why?
|
Brachytherapy | 1 | 2016 | 1240 | 0.320 |
Why?
|
Graft Occlusion, Vascular | 3 | 2024 | 560 | 0.310 |
Why?
|
Retrospective Studies | 39 | 2024 | 80301 | 0.310 |
Why?
|
Debridement | 2 | 2010 | 492 | 0.300 |
Why?
|
Aneurysm, False | 3 | 2020 | 257 | 0.300 |
Why?
|
Pericardium | 1 | 2012 | 675 | 0.290 |
Why?
|
Device Removal | 3 | 2021 | 634 | 0.280 |
Why?
|
Humans | 97 | 2024 | 760261 | 0.280 |
Why?
|
Kaplan-Meier Estimate | 9 | 2024 | 6545 | 0.270 |
Why?
|
Endarterectomy, Carotid | 1 | 2012 | 560 | 0.270 |
Why?
|
Ultrasonography, Doppler, Duplex | 3 | 2024 | 200 | 0.270 |
Why?
|
Arteriovenous Shunt, Surgical | 2 | 2022 | 294 | 0.240 |
Why?
|
Carotid Stenosis | 1 | 2012 | 872 | 0.230 |
Why?
|
Leg | 3 | 2016 | 1091 | 0.230 |
Why?
|
Viscera | 1 | 2004 | 138 | 0.230 |
Why?
|
Postoperative Complications | 14 | 2024 | 15680 | 0.220 |
Why?
|
Constriction, Pathologic | 3 | 2024 | 1098 | 0.220 |
Why?
|
Thymus Gland | 3 | 2004 | 1246 | 0.220 |
Why?
|
Chi-Square Distribution | 6 | 2016 | 3466 | 0.210 |
Why?
|
Heart Transplantation | 8 | 2005 | 3217 | 0.210 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2024 | 97 | 0.210 |
Why?
|
Recovery of Function | 3 | 2024 | 2982 | 0.210 |
Why?
|
Research Subjects | 2 | 2021 | 249 | 0.200 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2010 | 693 | 0.200 |
Why?
|
Arteries | 1 | 2007 | 1126 | 0.200 |
Why?
|
Patient Selection | 7 | 2024 | 4276 | 0.190 |
Why?
|
Male | 57 | 2024 | 359413 | 0.170 |
Why?
|
Vascular Fistula | 1 | 2020 | 50 | 0.170 |
Why?
|
Aged | 46 | 2024 | 168995 | 0.170 |
Why?
|
Mesenteric Artery, Superior | 2 | 2014 | 95 | 0.170 |
Why?
|
Gift Giving | 1 | 2020 | 76 | 0.170 |
Why?
|
Multivariate Analysis | 8 | 2024 | 12156 | 0.170 |
Why?
|
Financial Support | 1 | 2020 | 116 | 0.170 |
Why?
|
Chronic Disease | 6 | 2024 | 9283 | 0.170 |
Why?
|
Proportional Hazards Models | 9 | 2024 | 12532 | 0.170 |
Why?
|
Alloys | 1 | 2019 | 113 | 0.170 |
Why?
|
Intestinal Fistula | 1 | 2020 | 143 | 0.170 |
Why?
|
Subclavian Artery | 1 | 2019 | 133 | 0.160 |
Why?
|
Risk Assessment | 14 | 2024 | 24086 | 0.160 |
Why?
|
Middle Aged | 43 | 2024 | 220175 | 0.160 |
Why?
|
Cardiovascular Abnormalities | 1 | 2019 | 143 | 0.160 |
Why?
|
Credentialing | 1 | 2019 | 115 | 0.160 |
Why?
|
Boston | 4 | 2016 | 9282 | 0.160 |
Why?
|
Female | 56 | 2024 | 391011 | 0.160 |
Why?
|
Health Care Sector | 1 | 2020 | 196 | 0.150 |
Why?
|
Prospective Studies | 12 | 2024 | 54263 | 0.150 |
Why?
|
Aged, 80 and over | 21 | 2024 | 58947 | 0.150 |
Why?
|
Research Personnel | 2 | 2019 | 584 | 0.150 |
Why?
|
Myxoma | 1 | 2017 | 114 | 0.140 |
Why?
|
Databases, Factual | 6 | 2024 | 8018 | 0.140 |
Why?
|
Vascular Diseases | 3 | 2024 | 1180 | 0.140 |
Why?
|
Embolectomy | 1 | 2017 | 129 | 0.140 |
Why?
|
Aorta, Thoracic | 3 | 2011 | 1097 | 0.140 |
Why?
|
Magnetic Resonance Angiography | 4 | 2021 | 1430 | 0.140 |
Why?
|
Sample Size | 1 | 2019 | 840 | 0.130 |
Why?
|
Prosthesis-Related Infections | 1 | 2021 | 486 | 0.130 |
Why?
|
Intraoperative Care | 1 | 2019 | 768 | 0.130 |
Why?
|
Recurrence | 4 | 2016 | 8487 | 0.130 |
Why?
|
Aortography | 2 | 2018 | 419 | 0.130 |
Why?
|
North America | 2 | 2019 | 1282 | 0.130 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2015 | 26 | 0.120 |
Why?
|
Retreatment | 1 | 2016 | 600 | 0.120 |
Why?
|
Frail Elderly | 1 | 2020 | 747 | 0.120 |
Why?
|
Comprehension | 1 | 2020 | 613 | 0.120 |
Why?
|
Hematoma | 2 | 2012 | 769 | 0.120 |
Why?
|
Embolism | 1 | 2017 | 408 | 0.120 |
Why?
|
Specialization | 1 | 2019 | 779 | 0.120 |
Why?
|
Heart Neoplasms | 1 | 2017 | 360 | 0.120 |
Why?
|
Informed Consent | 1 | 2020 | 1007 | 0.110 |
Why?
|
Deglutition Disorders | 1 | 2019 | 627 | 0.110 |
Why?
|
Thrombosis | 2 | 2022 | 3052 | 0.110 |
Why?
|
Aorta | 1 | 2021 | 2042 | 0.110 |
Why?
|
Registries | 4 | 2021 | 8449 | 0.110 |
Why?
|
Angiography | 2 | 2016 | 1605 | 0.110 |
Why?
|
Interdisciplinary Communication | 2 | 2019 | 934 | 0.110 |
Why?
|
Vocal Cord Paralysis | 2 | 2009 | 272 | 0.110 |
Why?
|
Emergencies | 1 | 2019 | 1217 | 0.110 |
Why?
|
Anastomosis, Surgical | 1 | 2016 | 983 | 0.100 |
Why?
|
Cost-Benefit Analysis | 2 | 2016 | 5507 | 0.100 |
Why?
|
Aortic Diseases | 1 | 2018 | 736 | 0.100 |
Why?
|
Reading | 1 | 1996 | 530 | 0.100 |
Why?
|
Endoleak | 1 | 2012 | 105 | 0.100 |
Why?
|
Lipids | 1 | 2023 | 3336 | 0.100 |
Why?
|
Cyclosporine | 4 | 2004 | 778 | 0.100 |
Why?
|
Kidney Transplantation | 4 | 2021 | 4215 | 0.100 |
Why?
|
Tomography, Spiral Computed | 1 | 2012 | 273 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10340 | 0.090 |
Why?
|
Radiography | 4 | 2014 | 6965 | 0.090 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 718 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2017 | 938 | 0.090 |
Why?
|
Esophageal Cyst | 1 | 2010 | 13 | 0.090 |
Why?
|
Syndrome | 2 | 2024 | 3278 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2024 | 1866 | 0.090 |
Why?
|
Survival Rate | 6 | 2020 | 12806 | 0.090 |
Why?
|
Regional Blood Flow | 1 | 2014 | 1490 | 0.090 |
Why?
|
Paranasal Sinus Neoplasms | 4 | 1994 | 241 | 0.090 |
Why?
|
New England | 1 | 2013 | 1045 | 0.090 |
Why?
|
Streptococcal Infections | 1 | 2014 | 617 | 0.080 |
Why?
|
Aortitis | 1 | 2010 | 74 | 0.080 |
Why?
|
Substance Abuse, Intravenous | 1 | 2014 | 529 | 0.080 |
Why?
|
Flank Pain | 1 | 2009 | 43 | 0.080 |
Why?
|
Vascular Neoplasms | 1 | 2011 | 167 | 0.080 |
Why?
|
Aneurysm, Ruptured | 1 | 2014 | 460 | 0.080 |
Why?
|
Clinical Protocols | 1 | 2015 | 1439 | 0.080 |
Why?
|
Pain | 1 | 2024 | 5066 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 3967 | 0.080 |
Why?
|
Renal Dialysis | 2 | 2022 | 1802 | 0.080 |
Why?
|
Tunica Intima | 1 | 2011 | 459 | 0.080 |
Why?
|
Phlebography | 1 | 2009 | 325 | 0.080 |
Why?
|
Radiation Dosage | 1 | 2016 | 1957 | 0.080 |
Why?
|
Hematuria | 1 | 2009 | 233 | 0.080 |
Why?
|
Propensity Score | 2 | 2013 | 1918 | 0.080 |
Why?
|
Postoperative Hemorrhage | 1 | 2012 | 422 | 0.080 |
Why?
|
Laryngeal Neoplasms | 3 | 2004 | 514 | 0.080 |
Why?
|
Varicose Veins | 1 | 2009 | 155 | 0.070 |
Why?
|
Cardiology | 1 | 2019 | 1723 | 0.070 |
Why?
|
Hypoparathyroidism | 1 | 2009 | 136 | 0.070 |
Why?
|
Neck Dissection | 1 | 2009 | 201 | 0.070 |
Why?
|
Upper Extremity | 1 | 2012 | 661 | 0.070 |
Why?
|
Ethmoid Sinus | 3 | 1994 | 57 | 0.070 |
Why?
|
Visual Perception | 1 | 1996 | 1374 | 0.070 |
Why?
|
Prostheses and Implants | 2 | 2005 | 1272 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3696 | 0.070 |
Why?
|
Tibial Arteries | 1 | 2007 | 60 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7468 | 0.070 |
Why?
|
Adult | 22 | 2024 | 219847 | 0.070 |
Why?
|
Graft Survival | 5 | 2005 | 3793 | 0.070 |
Why?
|
Pharyngeal Neoplasms | 4 | 1988 | 113 | 0.070 |
Why?
|
Swine | 8 | 2005 | 5902 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3598 | 0.070 |
Why?
|
Prosthesis Design | 3 | 2012 | 2127 | 0.070 |
Why?
|
Cattle | 1 | 2012 | 3847 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 6 | 2014 | 20484 | 0.060 |
Why?
|
Severity of Illness Index | 5 | 2019 | 15827 | 0.060 |
Why?
|
Inguinal Canal | 1 | 2005 | 72 | 0.060 |
Why?
|
Cyanoacrylates | 1 | 2005 | 46 | 0.060 |
Why?
|
Cerebrovascular Circulation | 1 | 1996 | 2731 | 0.060 |
Why?
|
Immunosuppressive Agents | 5 | 2005 | 4168 | 0.060 |
Why?
|
United States | 10 | 2024 | 72363 | 0.060 |
Why?
|
Iliac Vein | 1 | 2004 | 70 | 0.060 |
Why?
|
Swine, Miniature | 6 | 2005 | 959 | 0.060 |
Why?
|
Comorbidity | 3 | 2016 | 10552 | 0.060 |
Why?
|
Tissue Adhesives | 1 | 2005 | 172 | 0.060 |
Why?
|
Thyroid Cartilage | 1 | 2003 | 43 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3520 | 0.060 |
Why?
|
Transplantation Chimera | 3 | 2001 | 595 | 0.060 |
Why?
|
Mycophenolic Acid | 1 | 2005 | 343 | 0.050 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 695 | 0.050 |
Why?
|
Glottis | 1 | 2004 | 214 | 0.050 |
Why?
|
Intention to Treat Analysis | 1 | 2024 | 422 | 0.050 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1529 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6830 | 0.050 |
Why?
|
Lymphoma, Follicular | 1 | 2006 | 453 | 0.050 |
Why?
|
Cisplatin | 6 | 2002 | 1642 | 0.050 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2004 | 1446 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2004 | 1354 | 0.050 |
Why?
|
Prevalence | 2 | 2019 | 15687 | 0.050 |
Why?
|
Health Care Costs | 1 | 2015 | 3257 | 0.050 |
Why?
|
Anesthesia, Local | 1 | 2003 | 276 | 0.050 |
Why?
|
Transplantation, Homologous | 4 | 2004 | 4814 | 0.050 |
Why?
|
Aortic Rupture | 1 | 2004 | 313 | 0.050 |
Why?
|
Young Adult | 3 | 2024 | 58673 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2004 | 4024 | 0.050 |
Why?
|
Vena Cava, Inferior | 1 | 2024 | 458 | 0.050 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2000 | 57 | 0.040 |
Why?
|
Adolescent | 5 | 2024 | 87747 | 0.040 |
Why?
|
Length of Stay | 3 | 2021 | 6472 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2004 | 11708 | 0.040 |
Why?
|
Ferrosoferric Oxide | 1 | 2021 | 348 | 0.040 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 935 | 0.040 |
Why?
|
Sarcoma | 1 | 2011 | 1786 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4938 | 0.040 |
Why?
|
Homozygote | 1 | 2004 | 1786 | 0.040 |
Why?
|
Isoantigens | 1 | 2001 | 552 | 0.040 |
Why?
|
New Zealand | 1 | 2019 | 355 | 0.040 |
Why?
|
Immunoglobulin M | 1 | 2004 | 1529 | 0.040 |
Why?
|
Graft Rejection | 5 | 2005 | 4423 | 0.040 |
Why?
|
Heart Function Tests | 1 | 2019 | 319 | 0.040 |
Why?
|
Combined Modality Therapy | 11 | 2015 | 8551 | 0.040 |
Why?
|
Follow-Up Studies | 7 | 2020 | 39254 | 0.040 |
Why?
|
Carotid Artery Diseases | 1 | 2005 | 881 | 0.040 |
Why?
|
Deglutition | 1 | 2019 | 208 | 0.040 |
Why?
|
Transplantation Immunology | 1 | 2000 | 532 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5884 | 0.040 |
Why?
|
Blood Flow Velocity | 1 | 2022 | 1375 | 0.040 |
Why?
|
Algorithms | 2 | 2016 | 13967 | 0.040 |
Why?
|
Haplotypes | 1 | 2004 | 2764 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2011 | 6457 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2019 | 269 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2004 | 1765 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2017 | 334 | 0.030 |
Why?
|
Skin Transplantation | 1 | 2001 | 1083 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2128 | 0.030 |
Why?
|
Thyroid Neoplasms | 1 | 2009 | 2332 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2004 | 2378 | 0.030 |
Why?
|
Conflict of Interest | 1 | 2020 | 549 | 0.030 |
Why?
|
Preoperative Care | 1 | 2024 | 2255 | 0.030 |
Why?
|
Pneumonectomy | 1 | 2002 | 1110 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4317 | 0.030 |
Why?
|
Blood Pressure | 1 | 2010 | 8523 | 0.030 |
Why?
|
Coronary Disease | 2 | 2000 | 5993 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2021 | 5420 | 0.030 |
Why?
|
Thymectomy | 3 | 2000 | 194 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2010 | 7400 | 0.030 |
Why?
|
Specialties, Surgical | 1 | 2019 | 389 | 0.030 |
Why?
|
Disclosure | 1 | 2020 | 738 | 0.030 |
Why?
|
Papilloma, Inverted | 1 | 1994 | 19 | 0.030 |
Why?
|
Odds Ratio | 2 | 2016 | 9712 | 0.030 |
Why?
|
Immune Tolerance | 2 | 2000 | 2299 | 0.030 |
Why?
|
Medicare | 2 | 2024 | 6771 | 0.030 |
Why?
|
Organ Transplantation | 1 | 2004 | 1150 | 0.030 |
Why?
|
Geniculate Bodies | 1 | 1994 | 154 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2004 | 5873 | 0.030 |
Why?
|
Survival Analysis | 2 | 2004 | 10185 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 1996 | 1121 | 0.030 |
Why?
|
Dyslexia | 1 | 1994 | 210 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2018 | 1206 | 0.030 |
Why?
|
Pancreatic Elastase | 1 | 2012 | 128 | 0.030 |
Why?
|
International Cooperation | 1 | 2019 | 1436 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3433 | 0.030 |
Why?
|
Laryngeal Cartilages | 1 | 1992 | 23 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2009 | 9274 | 0.030 |
Why?
|
Carcinoma | 3 | 2009 | 2334 | 0.030 |
Why?
|
Animals | 9 | 2012 | 167940 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1500 | 0.030 |
Why?
|
Cerebral Angiography | 1 | 2017 | 1272 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2019 | 1534 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2004 | 4546 | 0.020 |
Why?
|
Actuarial Analysis | 4 | 1994 | 375 | 0.020 |
Why?
|
Nose Neoplasms | 1 | 1994 | 249 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2005 | 2880 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2002 | 2811 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2000 | 2063 | 0.020 |
Why?
|
Heart | 1 | 2004 | 4392 | 0.020 |
Why?
|
Hearing | 1 | 1994 | 501 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2311 | 0.020 |
Why?
|
Endocarditis, Bacterial | 1 | 2014 | 445 | 0.020 |
Why?
|
Carcinoid Tumor | 1 | 1992 | 228 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2011 | 2007 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11064 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15273 | 0.020 |
Why?
|
Bleomycin | 2 | 1988 | 496 | 0.020 |
Why?
|
Probability | 2 | 2005 | 2476 | 0.020 |
Why?
|
Motivation | 1 | 2019 | 1990 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25928 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3106 | 0.020 |
Why?
|
Stroke | 1 | 2012 | 9945 | 0.020 |
Why?
|
Functional Laterality | 1 | 1996 | 2253 | 0.020 |
Why?
|
Lactobacillus | 1 | 2010 | 204 | 0.020 |
Why?
|
Radiopharmaceuticals | 2 | 2011 | 2633 | 0.020 |
Why?
|
Databases as Topic | 1 | 2011 | 474 | 0.020 |
Why?
|
Neoplasm Staging | 5 | 2011 | 11141 | 0.020 |
Why?
|
Ear Neoplasms | 1 | 1989 | 118 | 0.020 |
Why?
|
Visual Cortex | 1 | 1996 | 1089 | 0.020 |
Why?
|
Ear Canal | 1 | 1989 | 146 | 0.020 |
Why?
|
Pharyngectomy | 1 | 1988 | 44 | 0.020 |
Why?
|
Fluorouracil | 5 | 1994 | 1630 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2014 | 1064 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2010 | 349 | 0.020 |
Why?
|
Skin | 1 | 2001 | 4468 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3903 | 0.020 |
Why?
|
Contrast Media | 2 | 2012 | 5301 | 0.020 |
Why?
|
Ear, Middle | 1 | 1989 | 337 | 0.020 |
Why?
|
Endosonography | 1 | 2010 | 604 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3762 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3159 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3870 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2010 | 1111 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4900 | 0.010 |
Why?
|
Intracranial Aneurysm | 1 | 2014 | 1276 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 12968 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2012 | 6242 | 0.010 |
Why?
|
Axilla | 1 | 2006 | 618 | 0.010 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2014 | 1583 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2002 | 5248 | 0.010 |
Why?
|
Thyroidectomy | 1 | 2009 | 903 | 0.010 |
Why?
|
Carotid Artery, Internal | 1 | 2005 | 438 | 0.010 |
Why?
|
Incidence | 2 | 2012 | 21378 | 0.010 |
Why?
|
Esophagus | 1 | 1988 | 1023 | 0.010 |
Why?
|
Voice Quality | 1 | 2003 | 226 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2006 | 880 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2010 | 1666 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8621 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13311 | 0.010 |
Why?
|
Accidents, Traffic | 1 | 2006 | 814 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2005 | 2120 | 0.010 |
Why?
|
Leukocyte Transfusion | 1 | 2000 | 56 | 0.010 |
Why?
|
Morbidity | 1 | 2005 | 1765 | 0.010 |
Why?
|
Cicatrix | 1 | 2005 | 781 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1996 | 5755 | 0.010 |
Why?
|
Mouth Neoplasms | 1 | 1985 | 593 | 0.010 |
Why?
|
Catheterization | 1 | 2005 | 1432 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18415 | 0.010 |
Why?
|
Massachusetts | 1 | 2012 | 8805 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2012 | 12412 | 0.010 |
Why?
|
Lymph Node Excision | 3 | 1992 | 1305 | 0.010 |
Why?
|
Laryngectomy | 2 | 1992 | 243 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2002 | 13249 | 0.010 |
Why?
|
Esophageal Neoplasms | 1 | 1988 | 1651 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 1999 | 717 | 0.010 |
Why?
|
Major Histocompatibility Complex | 1 | 2000 | 928 | 0.010 |
Why?
|
Transplantation Tolerance | 1 | 2001 | 605 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2000 | 1351 | 0.010 |
Why?
|
Adenocarcinoma | 2 | 1994 | 6310 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2002 | 2897 | 0.010 |
Why?
|
Neurons | 1 | 1994 | 9416 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2006 | 3491 | 0.010 |
Why?
|
Wound Healing | 1 | 2005 | 2786 | 0.010 |
Why?
|
Ethmoid Bone | 1 | 1994 | 35 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 2 | 1994 | 3531 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2005 | 3451 | 0.010 |
Why?
|
Cohort Studies | 2 | 2005 | 41317 | 0.010 |
Why?
|
Tissue Donors | 1 | 2001 | 2314 | 0.010 |
Why?
|
Remission Induction | 1 | 1994 | 2394 | 0.000 |
Why?
|
Hematopoietic Stem Cells | 1 | 2000 | 3390 | 0.000 |
Why?
|
Myocardium | 1 | 2000 | 4688 | 0.000 |
Why?
|
Reference Values | 1 | 1994 | 4920 | 0.000 |
Why?
|
Neck | 1 | 1992 | 730 | 0.000 |
Why?
|
Child | 1 | 2015 | 79758 | 0.000 |
Why?
|
Vincristine | 1 | 1988 | 1038 | 0.000 |
Why?
|
Hypopharyngeal Neoplasms | 1 | 1985 | 51 | 0.000 |
Why?
|
Endoscopy | 1 | 1994 | 1841 | 0.000 |
Why?
|
Models, Biological | 1 | 1999 | 9468 | 0.000 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2001 | 5644 | 0.000 |
Why?
|
Neoplasm Invasiveness | 1 | 1991 | 3618 | 0.000 |
Why?
|
Cyclophosphamide | 1 | 1988 | 2220 | 0.000 |
Why?
|
Methotrexate | 1 | 1988 | 1717 | 0.000 |
Why?
|
Prognosis | 2 | 1994 | 29636 | 0.000 |
Why?
|
Oropharyngeal Neoplasms | 1 | 1985 | 491 | 0.000 |
Why?
|
Lymphatic Metastasis | 1 | 1986 | 2945 | 0.000 |
Why?
|